Sina Ampholeish
$0.00
Introduction
This product is a topical nanoliposomal gel 0.4% amphotericin B which produced for the treatment of cutaneous leishmaniasis and can be topically applied. Amphotericin B is the most effective drug for the treatment of fungal and protozoan infections such as leishmaniasis. Due to renal toxicity caused by this drug, liposomal formulations can be used for targeted drug delivery. The liposomal form of this drug reduces its destructive effects on the body and increases its penetration and transfer to the surface of the fungi.
Application
- Treatment of cutaneous leishmaniasis
- Effective in the treatment of topical fungal diseases
Advantage of Using Nanotechnology
Liposomes are the most widely used antimicrobial drug delivery system. The major distinguishing feature of liposomes is its lipid bilayer structure, which mimics cell membranes and can readily fuse with infectious microbes. By directly fusing with bacterial membranes, the drug payloads of liposomes can be released to the cell membranes or the interior of the bacteria.
Certificates and Standards
- NanoScale Certification
- Iran Ministry of Health Certification
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
General Inquiries
There are no inquiries yet.
Reviews
There are no reviews yet.